Notice
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
This was published under the 2024 to 2026 Starmer Labour government
Documents
PDF, 137 KB, 6 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email
defra.helpline@defra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
Updates to this page
Published 4 September 2024